ANDA 72860, held by Strides Pharma Intl. Albuterol Sulfate.
As of Nov 16, 2026, ANDA 72860 (Albuterol Sulfate), held by Strides Pharma Intl, was first approved by FDA on Dec 20, 1989, with 5 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 20, 1989 | Original application | Approved | None posted |
| Albuterol SulfateEQ 4MG BASE · tablet;oral | Albuterol Sulfate | Discontinued |
| Albuterol SulfateEQ 2MG BASE · tablet;oral | Albuterol Sulfate | Discontinued |
| Dec 30, 1993 | Supplement 4Manufacturing | Approved | None posted |
| Dec 13, 1993 | Supplement 5Labeling | Approved | None posted |
| Jul 22, 1993 | Supplement 3Labeling | Approved | None posted |
| Nov 23, 1990 | Supplement 2Labeling | Approved | None posted |
| Aug 31, 1990 | Supplement 1Labeling | Approved | None posted |
| Dec 20, 1989 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters